表紙
市場調査レポート

アジア太平洋地域の開発業務受託機関 (CRO) 市場

APAC Contract Research Organisation (CRO) Market

発行 Frost & Sullivan 商品コード 335337
出版日 ページ情報 英文 149 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
アジア太平洋地域の開発業務受託機関 (CRO) 市場 APAC Contract Research Organisation (CRO) Market
出版日: 2015年07月10日 ページ情報: 英文 149 Pages
概要

当レポートでは、アジア太平洋地域の開発業務受託機関 (CRO) 市場について調査分析し、収益予測 (相別、治療タイプ別) を提供するほか、主な問題点と課題、アンメットニーズ、市場の新興動向、サポートサービス (セントラルラボサービス、バイオアナリティクス、データ管理) 、市場促進要因・抑制要因、R&D動向などについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 市場概要

  • R&D支出
  • 市場の見通し
  • R&D市場情勢
  • CRO製品開発と商品化
  • CRO総合市場区分:臨床開発の段階別
  • CRO総合市場区分:治療サービス別
  • 主な市場動向
  • eクリニカルソリューション:概要
  • eクリニカルソリューション:応用と技術
  • バーチャルビジネスモデルの増加

第3章 競合戦略

  • 新しい市場機会
  • 合併・買収・パートナーシップの評価
  • 競合マトリクス

第4章 促進要因・抑制要因、動向

  • 市場促進要因
  • 市場抑制要因

第5章 予測と動向:CRO総合市場

  • 予測の前提条件
  • CRO総合市場エンジニアリング評価
  • CRO総合市場:収益予測
  • CRO総合市場:収益予測の考察
  • 主な市場動向

第6章 競合環境

  • 競合分析:市場シェア
  • 市場シェア分析
  • 競合環境
  • 競合分析:主要企業

第7章 前臨床試験

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第8章 第I相試験

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第9章 第II相試験

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第10章 第III相試験

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第11章 第IV相試験

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第12章 データ管理

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第13章 生物統計学

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第14章 医薬品安全性監視

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第15章 HEOR (医療経済評価)

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第16章 バイオアナリティクス

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第17章 セントラルラボサービス

  • 概要
  • 市場エンジニアリング評価
  • 収益予測
  • 主な市場動向

第18章 まとめ

第19章 付録

目次
Product Code: P86A-52

An Analysis of Trends Transforming the CRO Industry

The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-clinical trials to post marketing surveillance. Moreover, it provides detailed information on support services such as central laboratory services, bio-analytics, and data management. The research service also analyses market drivers and restraints, and provides market engineering measurements and research and development trends.

Key Questions This Study Will Answer

  • How will contract research outsourcing help in drug development by saving time and cost for manufacturers?
  • What is the impact of market growth in different countries in APAC?
  • Which are the major participants in the APAC CRO market and what are their market shares?
  • Which are the factors contributing toward expansion of CROs across the key therapeutic areas?
  • Are the products/services offered in APAC currently meeting customer needs or is additional development needed?
  • Which are the key market segments to look out for and what are the key trends in the APAC market?

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Key Findings (continued)
  • 4. Key Findings (continued)
  • 5. Key Findings (continued)
  • 6. Total CRO Market Size-By Stages of Clinical Development
  • 7. Market Size Estimation Methodology
  • 8. Scope and Segmentation
  • 9. Key Questions This Study Will Answer
  • 10. Total CRO Market Engineering Measurements
  • 11. Total CRO Market Engineering Measurements (continued)
  • 12. CEO's Perspective
  • 13. Key Companies to Watch
  • 14. Key Companies to Watch (continued)
  • 15. 3 Big Predictions

2. MARKET OVERVIEW

  • 1. R&D Spending-Pharmaceutical Drug Development
  • 2. Market Perspective
  • 3. R&D Market Landscape
  • 4. CRO Product Development and Commercialization
  • 5. Total CRO Market Segmentation-By Stages of Clinical Development
  • 6. Total CRO Market Segmentation-By Therapeutic Services
  • 7. Key Market Trends
  • 8. eClinical Solutions-An Overview
  • 9. eClinical Solutions-Applications and Technologies
  • 10. Rise of Virtual Business Models

3. COMPETITIVE PLAYBOOK

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. New Market Opportunities (continued)
  • 4. New Market Opportunities (continued)
  • 5. Merger, Acquisition and Partnership Assessment
  • 6. Merger, Acquisition and Partnership Assessment (continued)
  • 7. Competitive Matrix

4. DRIVERS, RESTRAINTS, AND TRENDS

  • 1. Market Drivers
  • 2. Market Restraints

5. FORECASTS AND TRENDS-TOTAL CRO MARKET

  • 1. Forecast Assumptions
  • 2. Total CRO Market Engineering Measurements
  • 3. Total CRO Market Engineering Measurements (continued)
  • 4. Total CRO Market-Revenue Forecast
  • 5. Total CRO Market-Revenue Forecast Discussion
  • 6. Key Market Trends
  • 7. Key Market Trends Explained
  • 8. Key Market Trends Explained (continued)
  • 9. Key Market Trends Explained (continued)

6. COMPETITIVE ENVIRONMENT

  • 1. Competitive Analysis-Market Share
  • 2. Market Share Analysis
  • 3. Competitive Environment
  • 4. Competitive Analysis-Selected Key Market Participants
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)
  • 7. Competitive Analysis-Selected Key Market Participants (continued)
  • 8. Competitive Analysis-Selected Key Market Participants (continued)
  • 9. Competitive Analysis-Selected Key Market Participants (continued)
  • 10. Competitive Analysis-Selected Key Market Participants (continued)
  • 11. Competitive Analysis-Selected Key Market Participants (continued)

7. PRE-CLINICAL TRIALS SEGMENT BREAKDOWN

  • 1. Pre-Clinical Trials Segment Overview
  • 2. Pre-Clinical Trials Segment-Market Engineering Measurements
  • 3. Pre-Clinical Trials Segment-Revenue Forecast
  • 4. Pre-Clinical Trials Segment-Revenue Forecast Discussion
  • 5. Pre-Clinical Trials Segment Key Trends

8. PHASE I TRIALS SEGMENT BREAKDOWN

  • 1. Phase I Trials Segment Overview
  • 2. Phase I Trials Segment-Market Engineering Measurements
  • 3. Phase I Trials Segment-Revenue Forecast
  • 4. Phase I Trials Segment-Revenue Forecast Discussion
  • 5. Phase I Trials Segment Key Trends

9. PHASE II TRIALS SEGMENT BREAKDOWN

  • 1. Phase II Trials Segment Overview
  • 2. Phase II Trials Segment-Market Engineering Measurements
  • 3. Phase II Trials Segment-Revenue Forecast
  • 4. Phase II Trials Segment-Revenue Forecast Discussion
  • 5. Phase II Trials Segment Key Trends*

10. PHASE III TRIALS SEGMENT BREAKDOWN

  • 1. Phase III Trials Segment Overview
  • 2. Phase III Trials Segment-Market Engineering Measurements
  • 3. Phase III Trials Segment-Revenue Forecast
  • 4. Phase III Trials Segment-Revenue Forecast Discussion
  • 5. Phase III Trials Segment Key Trends*

11. PHASE IV TRIALS SEGMENT BREAKDOWN

  • 1. Phase IV Trials Segment Overview
  • 2. Phase IV Trials Segment-Market Engineering Measurements
  • 3. Phase IV Trials Segment-Revenue Forecast
  • 4. Phase IV Trials Segment-Revenue Forecast Discussion
  • 5. Phase IV Trials Segment Key Trends

12. DATA MANAGEMENT SEGMENT BREAKDOWN

  • 1. Data Management Segment Overview
  • 2. Data Management Segment-Market Engineering Measurements
  • 3. Data Management Segment-Revenue Forecast
  • 4. Data Management Segment-Revenue Forecast Discussion
  • 5. Data Management Segment Key Trends

13. BIOSTATISTICS SEGMENT BREAKDOWN

  • 1. Biostatistics Segment Overview
  • 2. Biostatistics Segment-Market Engineering Measurements
  • 3. Biostatistics Segment-Revenue Forecast
  • 4. Biostatistics Segment-Revenue Forecast Discussion
  • 5. Biostatistics Segment Key Trends

14. PHARMACOVIGILANCE SEGMENT BREAKDOWN

  • 1. Pharmacovigilance Segment Overview
  • 2. Pharmacovigilance Segment-Market Engineering Measurements
  • 3. Pharmacovigilance Segment-Revenue Forecast
  • 4. Pharmacovigilance Segment-Revenue Forecast Discussion
  • 5. Pharmacovigilance Segment Key Trends

15. HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) SEGMENT BREAKDOWN

  • 1. HEOR Segment Overview
  • 2. HEOR Segment-Market Engineering Measurements
  • 3. HEOR Segment-Revenue Forecast
  • 4. HEOR Segment-Revenue Forecast Discussion
  • 5. HEOR Segment Key Trends

16. BIO-ANALYTICS SEGMENT

  • 1. Bio-Analytics Segment Overview
  • 2. Bio-Analytics Segment-Market Engineering Measurements
  • 3. Bio-Analytics Segment-Revenue Forecast
  • 4. Bio-Analytics Segment-Revenue Forecast Discussion
  • 5. Bio-Analytics Segment Key Trends

17. CENTRAL LABORATORY SERVICES SEGMENT BREAKDOWN

  • 1. Central Laboratory Services Segment Overview
  • 2. Central Laboratory Services Segment-Market Engineering Measurements
  • 3. Central Laboratory Services Segment-Revenue Forecast
  • 4. Central Laboratory Services Segment-Revenue Forecast Discussion
  • 5. Central Laboratory Services Segment Key Trends

18. THE LAST WORD

  • 1. 3 Big Predictions
  • 2. The Last Word-Discussion
  • 3. Legal Disclaimer

19. APPENDIX

  • 1. Methodology
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Restraints Explained
  • 5. Restraints Explained (continued)
  • 6. List of Exhibits
  • 7. List of Exhibits (continued)
  • 8. List of Exhibits (continued)
Back to Top